Zinian Zhao, Ying Zhang, Jing Han, Rong Ren, Guangming Li, Jinyu Yang
Introduction: This study aimed to examine the impact of Epstein-Barr virus (EBV) infection on the occurrence and prognosis of Henoch-Schönlein purpura (HSP).
Methodology: A total of 120 children diagnosed with HSP were selected as the experimental group, and 100 healthy children who underwent physical examinations were the control group. We compared renal function markers and quantified 24-hour urine protein in HSP children with different EBV infection statuses, and analyzed the association between EBV infection and Henoch-Schönlein purpura nephritis (HSPN).
Results: The detection rate of EBV-DNA load in the experimental group (30.83%) was significantly higher than that in the control group (10.00%) (p < 0.05). Among children with HSP, the detection rate of EBV-DNA load was significantly higher in those with abdominal involvement compared to those with joint or mixed types (p < 0.05). Serum levels of serum creatinine, blood urea nitrogen, and urine protein quantification were significantly higher in the EBV-positive group than in the EBV-negative group (p < 0.05). The detection rate of EBV-DNA load was significantly higher in the HSPN group compared to the non-HSPN group (p < 0.05). The detection rate of EBV-DNA load was significantly higher in the recurrence group than in the non-recurrence group (p < 0.05), and it was also higher in the relapse group compared to the non-relapse group (p < 0.05).
Conclusions: EBV infection is associated with the development of HSP; and gastrointestinal, joint, and renal damage. It is also an early warning sign for disease recurrence, which highlights its clinical significance.
{"title":"Impact of Epstein-Barr virus infection on the development and prognosis of allergic purpura.","authors":"Zinian Zhao, Ying Zhang, Jing Han, Rong Ren, Guangming Li, Jinyu Yang","doi":"10.3855/jidc.21020","DOIUrl":"https://doi.org/10.3855/jidc.21020","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to examine the impact of Epstein-Barr virus (EBV) infection on the occurrence and prognosis of Henoch-Schönlein purpura (HSP).</p><p><strong>Methodology: </strong>A total of 120 children diagnosed with HSP were selected as the experimental group, and 100 healthy children who underwent physical examinations were the control group. We compared renal function markers and quantified 24-hour urine protein in HSP children with different EBV infection statuses, and analyzed the association between EBV infection and Henoch-Schönlein purpura nephritis (HSPN).</p><p><strong>Results: </strong>The detection rate of EBV-DNA load in the experimental group (30.83%) was significantly higher than that in the control group (10.00%) (p < 0.05). Among children with HSP, the detection rate of EBV-DNA load was significantly higher in those with abdominal involvement compared to those with joint or mixed types (p < 0.05). Serum levels of serum creatinine, blood urea nitrogen, and urine protein quantification were significantly higher in the EBV-positive group than in the EBV-negative group (p < 0.05). The detection rate of EBV-DNA load was significantly higher in the HSPN group compared to the non-HSPN group (p < 0.05). The detection rate of EBV-DNA load was significantly higher in the recurrence group than in the non-recurrence group (p < 0.05), and it was also higher in the relapse group compared to the non-relapse group (p < 0.05).</p><p><strong>Conclusions: </strong>EBV infection is associated with the development of HSP; and gastrointestinal, joint, and renal damage. It is also an early warning sign for disease recurrence, which highlights its clinical significance.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1223-1230"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuxiang Li, Xia Wang, Lidi Zhang, Yanxia Huang, Yong'an Liu
Background: Pneumonia with an empyema caused by anaerobic bacteria is rare but can be life-threatening, especially in immunocompromised patients.
Case presentation: A 67-year-old man with diabetes and hypertension who presented with pneumonia and pleural effusion and was unresponsive to initial broad-spectrum antibiotics is presented. Next-generation sequencing identified Parvimonas micra and other pathogens. Therefore, targeted therapy with levornidazole was initiated. The patient's condition improved significantly after this treatment.
Conclusions: This case highlights the importance of considering anaerobic bacteria in immunocompromised patients and the utility of next-generation sequencing in identifying atypical pathogens.
{"title":"Pneumonia, a pulmonary abscess, and an empyema caused by Parvimonas micra.","authors":"Yuxiang Li, Xia Wang, Lidi Zhang, Yanxia Huang, Yong'an Liu","doi":"10.3855/jidc.20550","DOIUrl":"https://doi.org/10.3855/jidc.20550","url":null,"abstract":"<p><strong>Background: </strong>Pneumonia with an empyema caused by anaerobic bacteria is rare but can be life-threatening, especially in immunocompromised patients.</p><p><strong>Case presentation: </strong>A 67-year-old man with diabetes and hypertension who presented with pneumonia and pleural effusion and was unresponsive to initial broad-spectrum antibiotics is presented. Next-generation sequencing identified Parvimonas micra and other pathogens. Therefore, targeted therapy with levornidazole was initiated. The patient's condition improved significantly after this treatment.</p><p><strong>Conclusions: </strong>This case highlights the importance of considering anaerobic bacteria in immunocompromised patients and the utility of next-generation sequencing in identifying atypical pathogens.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1262-1268"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Both aging and malignancy are associated with an increased risk of infections, including bloodstream infections. Despite their clinical significance, research concentrating on the epidemiology, outcomes, and risk factors influencing mortality in older cancer patients is still limited. This study aims to examine the epidemiology of bloodstream infections and factors contributing to mortality among older cancer patients.
Methodology: This retrospective cohort study was conducted at Etlik City Hospital from January to December 2023. The subjects included cancer patients aged 65 years and older who had experienced bloodstream infections and received a minimum of 48 hours of antimicrobial therapy. Data, including demographics, clinical features, microbiological findings, and antimicrobial therapy, were collected. Bloodstream infections were categorized as either hospital-acquired or community-acquired infections and further classified by their source.
Results: Among 160 bloodstream infection episodes observed, 68.8% of them occurred in patients with solid tumors, while 31.3% were found in those with hematological malignancies. Hospital-acquired infections comprised 78.8% of the total cases. Mortality was significantly associated with inappropriate initial antimicrobial therapy, carbapenem resistance, and multidrug resistance. Additionally, patients who presented with septic shock and fungal infections had higher mortality rates.
Conclusion: The findings underscore the urgent need for early implementation of appropriate antimicrobial therapy and effective infection control measures. The persistence of multidrug resistance and hospital-acquired infections presents critical challenges in reducing mortality rates among older cancer patients. The development of tailored infection management strategies and robust antimicrobial stewardship programs is essential for enhancing outcomes in cancer patients.
{"title":"Bloodstream infections in older cancer patients: epidemiology and risk factors for mortality.","authors":"Sabahat Çeken, Nurhayat Yılmaz, Can Hüseyin Hekimoğlu, Göknur Yapar Toros, Ayşegül İlhan Güleşen, Emine Merve Savaş, Burcu Altunay, Ebru Taşpınar Şen, Gönül Çiçek Şentürk","doi":"10.3855/jidc.21222","DOIUrl":"https://doi.org/10.3855/jidc.21222","url":null,"abstract":"<p><strong>Introduction: </strong>Both aging and malignancy are associated with an increased risk of infections, including bloodstream infections. Despite their clinical significance, research concentrating on the epidemiology, outcomes, and risk factors influencing mortality in older cancer patients is still limited. This study aims to examine the epidemiology of bloodstream infections and factors contributing to mortality among older cancer patients.</p><p><strong>Methodology: </strong>This retrospective cohort study was conducted at Etlik City Hospital from January to December 2023. The subjects included cancer patients aged 65 years and older who had experienced bloodstream infections and received a minimum of 48 hours of antimicrobial therapy. Data, including demographics, clinical features, microbiological findings, and antimicrobial therapy, were collected. Bloodstream infections were categorized as either hospital-acquired or community-acquired infections and further classified by their source.</p><p><strong>Results: </strong>Among 160 bloodstream infection episodes observed, 68.8% of them occurred in patients with solid tumors, while 31.3% were found in those with hematological malignancies. Hospital-acquired infections comprised 78.8% of the total cases. Mortality was significantly associated with inappropriate initial antimicrobial therapy, carbapenem resistance, and multidrug resistance. Additionally, patients who presented with septic shock and fungal infections had higher mortality rates.</p><p><strong>Conclusion: </strong>The findings underscore the urgent need for early implementation of appropriate antimicrobial therapy and effective infection control measures. The persistence of multidrug resistance and hospital-acquired infections presents critical challenges in reducing mortality rates among older cancer patients. The development of tailored infection management strategies and robust antimicrobial stewardship programs is essential for enhancing outcomes in cancer patients.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1205-1215"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Clostridioides difficile often causes hospital-acquired diarrhea, leading to unfavorable treatment outcomes. This study investigates CDI treatment outcomes and factors affecting severity and mortality at a university hospital in Thailand.
Methodology: A retrospective study was conducted from June 2019 to December 2021. The primary endpoints were treatment outcomes with a 95% CI. Univariable and multivariable Cox regression analyses determined risk factors for severe CDI and 30-day mortality.
Results: Of 187 patients receiving a diagnosis of and receiving treatment for CDI, 103 patients (55.8%) presented non-severe CDI, and 84 patients (44.2%) had severe CDI. The 30-day mortality rate of CDI was 24.1%, which was significantly higher in the severe group (36.9 vs. 13.6%, p ≤ 0.001). Multivariable analysis revealed the independent risk factor for severe CDI was chronic kidney disease (aOR 15.16, 95% CI 6.3, 36.48), and risk factors for all-cause mortality at 30 days were ICU admission (aOR 3.56, 95%CI 1.48, 8.56) and carbapenem exposure (aOR 2.79, 95% CI 1.17, 6.68).
Conclusions: This study demonstrated high mortality rates and a significant incidence of refractory and recurrent infections in the severe CDI group. Chronic kidney disease was an independent risk factor for severe CDI. ICU admission and carbapenem exposure were independent risk factors for all-cause mortality.
{"title":"Treatment outcomes and risk factors for severity and mortality in Clostridioides difficile infection: a single-center study in Thailand.","authors":"Thamonwan Chaemprida, Worapong Nasomsong","doi":"10.3855/jidc.20742","DOIUrl":"https://doi.org/10.3855/jidc.20742","url":null,"abstract":"<p><strong>Introduction: </strong>Clostridioides difficile often causes hospital-acquired diarrhea, leading to unfavorable treatment outcomes. This study investigates CDI treatment outcomes and factors affecting severity and mortality at a university hospital in Thailand.</p><p><strong>Methodology: </strong>A retrospective study was conducted from June 2019 to December 2021. The primary endpoints were treatment outcomes with a 95% CI. Univariable and multivariable Cox regression analyses determined risk factors for severe CDI and 30-day mortality.</p><p><strong>Results: </strong>Of 187 patients receiving a diagnosis of and receiving treatment for CDI, 103 patients (55.8%) presented non-severe CDI, and 84 patients (44.2%) had severe CDI. The 30-day mortality rate of CDI was 24.1%, which was significantly higher in the severe group (36.9 vs. 13.6%, p ≤ 0.001). Multivariable analysis revealed the independent risk factor for severe CDI was chronic kidney disease (aOR 15.16, 95% CI 6.3, 36.48), and risk factors for all-cause mortality at 30 days were ICU admission (aOR 3.56, 95%CI 1.48, 8.56) and carbapenem exposure (aOR 2.79, 95% CI 1.17, 6.68).</p><p><strong>Conclusions: </strong>This study demonstrated high mortality rates and a significant incidence of refractory and recurrent infections in the severe CDI group. Chronic kidney disease was an independent risk factor for severe CDI. ICU admission and carbapenem exposure were independent risk factors for all-cause mortality.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1196-1204"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Candida auris is a yeast that has a high mortality rate in critically ill patients and is resistant to many antifungal agents enhancing its clinical importance. Our study identifies the risk factors for C. auris invasive infection, antifungal susceptibility, and outcomes.
Methodology: A total of 100 adults with C. auris isolated in any clinical specimen between 07.01.2022 and 31.12.2023 were enrolled in this retrospective cohort study. Data were obtained via retrospective screening of patient files. C. auris identification was performed by MALDI-TOF MS. Antifungal susceptibility was carried out by VITEK 2 and CDC methodology. Colonized and infected patients were compared to assess the risk factors for and outcomes of invasive infection.
Results: Twenty (20%) patients developed invasive infections, with 16 (80%) having candidemia. Age, Candida score, prior antifungal agent use, number of previously used antibiotics ≥ 3, presence of central venous catheter or nasogastric catheter, and being monitored out of burn unit were the risk factors, and Candida score was identified as an independent risk factor for invasive infection development. Of the isolates, 55% were resistant to fluconazole and 100% were resistant to amphotericin B. No micafungin resistance was detected. The overall mortality rate in patients with invasive infection was 75%.
Conclusions: Knowing the risk factors for invasive infection will help early initiation of empirical antifungal therapy by ensuring early identification of high-risk patients, and Candida score appears to be an effective method for this. Revealing antifungal susceptibility will also guide the selection of appropriate empirical treatment.
{"title":"Increasing spread of Candida auris and investigation of risk factors for invasive infections in colonized patients.","authors":"Tuğba Arslan Gülen, Nida Akar, Ebru Oruç, Tuba Turunç, Koray Daş, Nurdan Ünlü, Aygün Uğurbekler","doi":"10.3855/jidc.20891","DOIUrl":"https://doi.org/10.3855/jidc.20891","url":null,"abstract":"<p><strong>Introduction: </strong>Candida auris is a yeast that has a high mortality rate in critically ill patients and is resistant to many antifungal agents enhancing its clinical importance. Our study identifies the risk factors for C. auris invasive infection, antifungal susceptibility, and outcomes.</p><p><strong>Methodology: </strong>A total of 100 adults with C. auris isolated in any clinical specimen between 07.01.2022 and 31.12.2023 were enrolled in this retrospective cohort study. Data were obtained via retrospective screening of patient files. C. auris identification was performed by MALDI-TOF MS. Antifungal susceptibility was carried out by VITEK 2 and CDC methodology. Colonized and infected patients were compared to assess the risk factors for and outcomes of invasive infection.</p><p><strong>Results: </strong>Twenty (20%) patients developed invasive infections, with 16 (80%) having candidemia. Age, Candida score, prior antifungal agent use, number of previously used antibiotics ≥ 3, presence of central venous catheter or nasogastric catheter, and being monitored out of burn unit were the risk factors, and Candida score was identified as an independent risk factor for invasive infection development. Of the isolates, 55% were resistant to fluconazole and 100% were resistant to amphotericin B. No micafungin resistance was detected. The overall mortality rate in patients with invasive infection was 75%.</p><p><strong>Conclusions: </strong>Knowing the risk factors for invasive infection will help early initiation of empirical antifungal therapy by ensuring early identification of high-risk patients, and Candida score appears to be an effective method for this. Revealing antifungal susceptibility will also guide the selection of appropriate empirical treatment.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1245-1252"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emre Bilgin, Tugba Arslan Gulen, Gokhan Kızılpınar, Gulistan Gul Işıkber, Can Sezer, Zeynel Abidin Tas, Ebru Oruc
Introduction: To evaluate the characteristics of patients who have undergone surgical operations due to brain abscess and to assess the risk factors for mortality and the outcomes.
Methodology: Patients who have undergone surgical operations due to brain abscess between January 2014 and January 2024 in our hospital were evaluated retrospectively. Patients were divided into 2 groups to determine poor outcome predictive factors.
Results: A total of 57 patients with brain abscess were evaluated. Brain abscess was developed after a surgical procedure in 33% of the patients. Of these patients, 44 (77%) recovered without sequelae, 3 cases had epilepsy, and 2 had hemiplegia. Comparing the patients with poor outcome and the patients with good outcome in terms of symptom duration, time to hospital admission, and C-reactive protein, erythrocyte sedimentation rate and procalcitonin values, we detected statistically significant difference only in erythrocyte sedimentation rate (p = 0.018). Patients with poor outcome had higher C-reactive protein and procalcitonin values and shorter symptom duration and time to hospital admission than the patients with good outcome. Multivariate logistic regression analysis revealed that erythrocyte sedimentation rate is a predictive factor for poor outcome.
Conclusions: Brain abscesses with high mortality and morbidity. Detailed questioning of symptom duration and time to hospital admission in patients presenting with headache who have or have not undergone surgical operation, precisely evaluating C-reactive protein, sedimentation, and procalcitonin values after performing necessary scanning procedures, and swiftly planning surgical and/or antibiotic treatment are associated with survival benefit.
{"title":"The characteristics of the cases with brain abscess and the analysis of the predictive factors for poor outcome.","authors":"Emre Bilgin, Tugba Arslan Gulen, Gokhan Kızılpınar, Gulistan Gul Işıkber, Can Sezer, Zeynel Abidin Tas, Ebru Oruc","doi":"10.3855/jidc.20676","DOIUrl":"https://doi.org/10.3855/jidc.20676","url":null,"abstract":"<p><strong>Introduction: </strong>To evaluate the characteristics of patients who have undergone surgical operations due to brain abscess and to assess the risk factors for mortality and the outcomes.</p><p><strong>Methodology: </strong>Patients who have undergone surgical operations due to brain abscess between January 2014 and January 2024 in our hospital were evaluated retrospectively. Patients were divided into 2 groups to determine poor outcome predictive factors.</p><p><strong>Results: </strong>A total of 57 patients with brain abscess were evaluated. Brain abscess was developed after a surgical procedure in 33% of the patients. Of these patients, 44 (77%) recovered without sequelae, 3 cases had epilepsy, and 2 had hemiplegia. Comparing the patients with poor outcome and the patients with good outcome in terms of symptom duration, time to hospital admission, and C-reactive protein, erythrocyte sedimentation rate and procalcitonin values, we detected statistically significant difference only in erythrocyte sedimentation rate (p = 0.018). Patients with poor outcome had higher C-reactive protein and procalcitonin values and shorter symptom duration and time to hospital admission than the patients with good outcome. Multivariate logistic regression analysis revealed that erythrocyte sedimentation rate is a predictive factor for poor outcome.</p><p><strong>Conclusions: </strong>Brain abscesses with high mortality and morbidity. Detailed questioning of symptom duration and time to hospital admission in patients presenting with headache who have or have not undergone surgical operation, precisely evaluating C-reactive protein, sedimentation, and procalcitonin values after performing necessary scanning procedures, and swiftly planning surgical and/or antibiotic treatment are associated with survival benefit.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1182-1188"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ShiQu Deng, YaLi Wu, PeiYun Hu, JianLiang Lin, Jingming Yao, Bin Wang
Introduction: Community-acquired pneumonia (CAP) is a common respiratory disease in children and a significant factor in child mortality.
Methodology: We aimed to investigate metagenomic next-generation sequencing (mNGS) technology to explore pathogens and epidemiological characteristics of pediatric CAP. We retrospectively analyzed mNGS detection and microbiological culture results of bronchoalveolar lavage fluid (BALF) and sputum samples from children with CAP.
Results: Mycoplasma pneumoniae was the predominant pathogen. Bacteria/fungi detection rates using mNGS in sputum and BALF were higher than those using microbiological culture (p < 0.05). Cytomegalovirus was the predominant pathogen in children aged 0-1; Mycoplasma pneumoniae was the predominant pathogen in those over 1. Haemophilus influenzae, Mycoplasma pneumoniae, human bocavirus 1, and Streptococcus pneumoniae were the predominant pathogens in spring, summer, autumn, and winter, respectively.
Conclusions: mNGS is superior to traditional microbiological culture for pediatric CAP potential pathogen detection. CAP pathogenic infection characteristics at different ages and seasons detected by mNGS will benefit clinical practitioners in the prevention and treatment of pediatric CAP in their local/regional areas.
{"title":"Detection of pathogens and epidemiological characteristics of community-acquired pneumonia in children using metagenomic next-generation sequencing.","authors":"ShiQu Deng, YaLi Wu, PeiYun Hu, JianLiang Lin, Jingming Yao, Bin Wang","doi":"10.3855/jidc.20668","DOIUrl":"https://doi.org/10.3855/jidc.20668","url":null,"abstract":"<p><strong>Introduction: </strong>Community-acquired pneumonia (CAP) is a common respiratory disease in children and a significant factor in child mortality.</p><p><strong>Methodology: </strong>We aimed to investigate metagenomic next-generation sequencing (mNGS) technology to explore pathogens and epidemiological characteristics of pediatric CAP. We retrospectively analyzed mNGS detection and microbiological culture results of bronchoalveolar lavage fluid (BALF) and sputum samples from children with CAP.</p><p><strong>Results: </strong>Mycoplasma pneumoniae was the predominant pathogen. Bacteria/fungi detection rates using mNGS in sputum and BALF were higher than those using microbiological culture (p < 0.05). Cytomegalovirus was the predominant pathogen in children aged 0-1; Mycoplasma pneumoniae was the predominant pathogen in those over 1. Haemophilus influenzae, Mycoplasma pneumoniae, human bocavirus 1, and Streptococcus pneumoniae were the predominant pathogens in spring, summer, autumn, and winter, respectively.</p><p><strong>Conclusions: </strong>mNGS is superior to traditional microbiological culture for pediatric CAP potential pathogen detection. CAP pathogenic infection characteristics at different ages and seasons detected by mNGS will benefit clinical practitioners in the prevention and treatment of pediatric CAP in their local/regional areas.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1189-1195"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: This study analyzed the age and sex distribution of COVID-19 patients during the initial three COVID-19 waves in Puducherry, India, from August 2020 to March 2022, to understand the distribution of infection across different demographic groups.
Methods: The disease surveillance program conducted at ICMR-Vector Control Research Centre processed 79,705 Throat Swab/Nasal Swab (TSNS) samples received from various institutions in Puducherry through the Integrated Disease Surveillance Program (IDSP). Real-time reverse-transcriptase-polymerase chain reaction (rRT-PCR) was performed following approved protocols.
Results: Test positivity rates during the second (14.6%) and third waves (25.1%) were significantly higher than the first wave (11.4%). In the first wave, children (p < 0.001) and elderly individuals (p = 0.017) had a lower risk of testing positive than adults. However, in the second wave, elderly individuals had a 1.12 (95% CI: 1.03 - 1.23) times greater risk of contracting COVID-19 (p = 0.013). Children had a lower risk of testing positive across all waves (p < 0.001). A significant sex difference was noted only in the first wave, with males having a 1.27 (1.18-1.37) times greater chance of being COVID-19 positive. The mean age of female patients was significantly younger than male patients in the third wave (p = 0.008). The third wave showed an increasing trend of infection across all age groups and sexes, especially among younger individuals.
Conclusions: The study highlights an increasing trend of infections across all age groups and sexes during the third wave. Micro-epidemiological analyses are crucial for developing targeted intervention strategies that address age and sex demographics effectively.
{"title":"Age and sex distribution trends of SARS-CoV-2 infections: Insights from three epidemic waves in Puducherry, India.","authors":"Lourduraj John De Britto, Arya Rahul, Dinesh Sundaram, Balakrishnan Vijayakumar, Thirumal Sankari, Muthukumaravel Subramanian, Raja Jeyapal Dinesh, Philip Raj Abraham, Panneer Devaraju, Yasin Nazeer, Ayyanar Elango, Balasubramaniyan Ramalingam, Kulandaisamy Athisaya Mary, Suchi Tyagi, Rituraj Niranjan, Paramasivan Rajaiah, Mayilsamy Muniaraj, Narendran Pradeep Kumar, Irudayaraj Geetha, Ananganallur Nagarajan Shriram, Adinarayanan Srividya, Vijesh Sreedhar Kuttiatt, Ashwani Kumar","doi":"10.3855/jidc.20689","DOIUrl":"https://doi.org/10.3855/jidc.20689","url":null,"abstract":"<p><strong>Introduction: </strong>This study analyzed the age and sex distribution of COVID-19 patients during the initial three COVID-19 waves in Puducherry, India, from August 2020 to March 2022, to understand the distribution of infection across different demographic groups.</p><p><strong>Methods: </strong>The disease surveillance program conducted at ICMR-Vector Control Research Centre processed 79,705 Throat Swab/Nasal Swab (TSNS) samples received from various institutions in Puducherry through the Integrated Disease Surveillance Program (IDSP). Real-time reverse-transcriptase-polymerase chain reaction (rRT-PCR) was performed following approved protocols.</p><p><strong>Results: </strong>Test positivity rates during the second (14.6%) and third waves (25.1%) were significantly higher than the first wave (11.4%). In the first wave, children (p < 0.001) and elderly individuals (p = 0.017) had a lower risk of testing positive than adults. However, in the second wave, elderly individuals had a 1.12 (95% CI: 1.03 - 1.23) times greater risk of contracting COVID-19 (p = 0.013). Children had a lower risk of testing positive across all waves (p < 0.001). A significant sex difference was noted only in the first wave, with males having a 1.27 (1.18-1.37) times greater chance of being COVID-19 positive. The mean age of female patients was significantly younger than male patients in the third wave (p = 0.008). The third wave showed an increasing trend of infection across all age groups and sexes, especially among younger individuals.</p><p><strong>Conclusions: </strong>The study highlights an increasing trend of infections across all age groups and sexes during the third wave. Micro-epidemiological analyses are crucial for developing targeted intervention strategies that address age and sex demographics effectively.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1143-1151"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Akemfua Fualefac, Jerome Fru-Cho, Patrick-Kofon Jokwi, Julius N Mbekem, Lucy Ma Ndip, Achiangia P Njukeng
Introduction: Despite increased national and international funding to combat the human immunodeficiency virus (HIV) pandemic, prison health services remain underfunded, resulting in poor HIV management among inmates. This study assessed viral suppression rates among HIV-positive inmates across four central prisons in Cameroon to evaluate the effectiveness of antiretroviral therapy (ART) in these settings.
Methodology: This cross-sectional study included four central prisons-prisons A, B, C, and D-each located in different regions of Cameroon. Data were obtained from patient records, and blood samples were collected from inmates eligible for viral load (VL) testing.
Results: A total of 268 inmates receiving first-line ART were enrolled. The overall viral suppression rate, defined as VL < 1000 copies/mL, was 89.9%. The suppression rates in the four prisons were 94.25%, 87.69%, 78.95%, and 50% for Prison C, D, A, and B, respectively. There was a strong association between viral suppression and the specific prison (p < 0.001). Inmates on dolutegravir (DTG)-based regimens had significantly higher suppression rates (p = 0.027). Moreover, prisons supported by the United States President's Emergency Plan for Acquired Immunodeficiency Syndrome (AIDS) Relief (PEPFAR) reported better suppression outcomes compared to non-PEPFAR-supported facilities (X²(1) = 13.28, p = 0.000268).
Conclusions: These findings underscore the disparities in HIV care across correctional facilities and highlight the need for harmonized clinical management of HIV in prisons. Ensuring equitable access to comprehensive HIV services is essential for achieving the 95% VL suppression target among incarcerated populations.
{"title":"HIV viral load suppression amongst the incarcerated populations in Cameroon.","authors":"Akemfua Fualefac, Jerome Fru-Cho, Patrick-Kofon Jokwi, Julius N Mbekem, Lucy Ma Ndip, Achiangia P Njukeng","doi":"10.3855/jidc.20765","DOIUrl":"https://doi.org/10.3855/jidc.20765","url":null,"abstract":"<p><strong>Introduction: </strong>Despite increased national and international funding to combat the human immunodeficiency virus (HIV) pandemic, prison health services remain underfunded, resulting in poor HIV management among inmates. This study assessed viral suppression rates among HIV-positive inmates across four central prisons in Cameroon to evaluate the effectiveness of antiretroviral therapy (ART) in these settings.</p><p><strong>Methodology: </strong>This cross-sectional study included four central prisons-prisons A, B, C, and D-each located in different regions of Cameroon. Data were obtained from patient records, and blood samples were collected from inmates eligible for viral load (VL) testing.</p><p><strong>Results: </strong>A total of 268 inmates receiving first-line ART were enrolled. The overall viral suppression rate, defined as VL < 1000 copies/mL, was 89.9%. The suppression rates in the four prisons were 94.25%, 87.69%, 78.95%, and 50% for Prison C, D, A, and B, respectively. There was a strong association between viral suppression and the specific prison (p < 0.001). Inmates on dolutegravir (DTG)-based regimens had significantly higher suppression rates (p = 0.027). Moreover, prisons supported by the United States President's Emergency Plan for Acquired Immunodeficiency Syndrome (AIDS) Relief (PEPFAR) reported better suppression outcomes compared to non-PEPFAR-supported facilities (X²(1) = 13.28, p = 0.000268).</p><p><strong>Conclusions: </strong>These findings underscore the disparities in HIV care across correctional facilities and highlight the need for harmonized clinical management of HIV in prisons. Ensuring equitable access to comprehensive HIV services is essential for achieving the 95% VL suppression target among incarcerated populations.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1239-1244"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Despite the HPV vaccine's efficacy in cervical cancer prevention, cervical cancer ranks second in prevalence among women, following breast cancer. Various factors negatively impact HPV vaccination uptake, with parents' knowledge and attitudes being particularly crucial in this regard.
Methodology: A cross-sectional study was conducted between February and May 2023, targeting parents in northern Albania. The standardized Vaccination and HPV Knowledge (THinK) questionnaire was used, and a random sampling methodology was applied. Data were collected at primary healthcare centers, targeting parents who were seeking various healthcare services.
Results: A total of 102 participants completed the questionnaire, yielding a response rate of 74%. The majority of parents were married (79.4%), female (82.4%), over 30 years of age, and residents of urban areas (67.6%). A low mean score was reported for both the vaccination rate of girls (1.79 ± 0.40) and the willingness to vaccinate them (1.31 ± 0.46). Of the participants, 15 (14.7%) parents expressed strong knowledge of vaccines, while only 6 (5.9%) had knowledge about HPV, and 52 (51%) expressed interest in receiving information about HPV vaccination. Three factors emerged, explaining 71.02% of the variance: knowledge about HPV and vaccination, side effects of the vaccines, and the impact of vaccinating girls on HPV vaccination uptake.
Conclusions: The study found that the identified factors-knowledge, side effects of vaccines, and vaccination attitudes-significantly influence HPV vaccination uptake. Co-creation activities involving parents, girls, and healthcare professionals are the most effective strategies to build trust and improve awareness among the target population regarding the HPV vaccine.
{"title":"The influence of parents' knowledge on HPV vaccine uptake - evidence from Albania.","authors":"Miranda Çela, Elinda Gjata, Enkeleda Sinaj, Vjollca Ndreu, Migena Gega, Orgeta Dervishi, Ledi Neçaj, Brizida Refatllari, Esmeralda Sinaj, Fatjona Kamberi","doi":"10.3855/jidc.20889","DOIUrl":"https://doi.org/10.3855/jidc.20889","url":null,"abstract":"<p><strong>Introduction: </strong>Despite the HPV vaccine's efficacy in cervical cancer prevention, cervical cancer ranks second in prevalence among women, following breast cancer. Various factors negatively impact HPV vaccination uptake, with parents' knowledge and attitudes being particularly crucial in this regard.</p><p><strong>Methodology: </strong>A cross-sectional study was conducted between February and May 2023, targeting parents in northern Albania. The standardized Vaccination and HPV Knowledge (THinK) questionnaire was used, and a random sampling methodology was applied. Data were collected at primary healthcare centers, targeting parents who were seeking various healthcare services.</p><p><strong>Results: </strong>A total of 102 participants completed the questionnaire, yielding a response rate of 74%. The majority of parents were married (79.4%), female (82.4%), over 30 years of age, and residents of urban areas (67.6%). A low mean score was reported for both the vaccination rate of girls (1.79 ± 0.40) and the willingness to vaccinate them (1.31 ± 0.46). Of the participants, 15 (14.7%) parents expressed strong knowledge of vaccines, while only 6 (5.9%) had knowledge about HPV, and 52 (51%) expressed interest in receiving information about HPV vaccination. Three factors emerged, explaining 71.02% of the variance: knowledge about HPV and vaccination, side effects of the vaccines, and the impact of vaccinating girls on HPV vaccination uptake.</p><p><strong>Conclusions: </strong>The study found that the identified factors-knowledge, side effects of vaccines, and vaccination attitudes-significantly influence HPV vaccination uptake. Co-creation activities involving parents, girls, and healthcare professionals are the most effective strategies to build trust and improve awareness among the target population regarding the HPV vaccine.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 8","pages":"1231-1238"},"PeriodicalIF":1.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145024541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}